Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Peter H R Riepenhausen
AddedFeb 15, 2024
UpdatedMay 1, 2026
Peter H R Riepenhausen

Peter H R Riepenhausen

Board Member, Sonitus Medical

Peter H R Riepenhausen's Career

Sonitus Medical
Sonitus Medical

San Mateo, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Peter H R Riepenhausen's Career

Sonitus Medical
Sonitus Medical
Seed$74.2M752006San Mateo, CA, US
Board Member· Board

Leadership at Sonitus Medical

Jan GarfinkleJan GarfinkleBoard Member
Amir AbolfathiAmir AbolfathiBoard Member
Mark FoleyMark FoleyBoard Member

Similar to Sonitus Medical

Soundwave HearingSoundwave HearingOak Brook, IL, USHearing Aids, Softwareest. 2017Soundwave HearingOak Brook, IL, US · est. 2017

Soundwave Hearing: A health tech firm developing smart hearing aids using machine learning.

Series A · $2.3M9
Sonitus TechnologiesSonitus TechnologiesSan Mateo, CA, USCommunication Devicesest. 2010Sonitus TechnologiesSan Mateo, CA, US · est. 2010

Sonitus Technologies provides innovative wireless communication devices, enabling real-time monitoring in challenging environments.

Series A · $11.8M30
Sonogen MedicalSonogen MedicalChevy Chase, MD, USMedical Devicesest. 2020Sonogen MedicalChevy Chase, MD, US · est. 2020

Sonogen Medical: Innovating ultrasonic devices for accelerated bone fracture healing and real-time feedback.

Seed · $245.7k4
SonicSurg InnovationsSonicSurg InnovationsLakeland, FL, USMedical Devicesest. 2009SonicSurg InnovationsLakeland, FL, US · est. 2009

SonicSurg Innovations: Florida-based medical device developer for treating trigger finger and broken bones.

Seed · $1.5M6

Peter H R Riepenhausen's Similar Executives & Operators

WILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoYun SeokYun SeokBoard Member · KakaoBrian KimBrian KimBoard Member · KakaoHong EuntaekHong EuntaekBoard Member · KakaoSong Ji-Ho 'DeanSong Ji-Ho 'DeanBoard Member · Kakao

People Similar to Peter H R Riepenhausen

Peter HausmannPeter HausmannBoard Member · CovestroPeter L RheinPeter L RheinBoard Member · Cohen & SteersPeter PauliPeter PauliBoard Member · SiC ProcessingPeter A A SaundersPeter A A SaundersBoard Member · TheragenicsPete ReineckePete ReineckeBoard Member · Deck Internet SolutionsDr Peter B RoemerDr Peter B RoemerBoard Member · ViewRay